Buys
Open market- Shares
- +5,000
- Avg price
- $0.4290
- Total value
- +$2,145
Randy H. Thurman - Director at Outlook Therapeutics, Inc.
Issuer-level insider activity
- Role
- Director
- Issuer ticker
- OTLK on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
Past-year transaction volume for Randy H. Thurman in Outlook Therapeutics, Inc.
Sells
Open market- Shares
- Avg price
- Total value
Net
Past year- Shares
- +5,000
- Share %
- 100%
- Total value
- +$2,145
Reported holdings for Randy H. Thurman in Outlook Therapeutics, Inc.
Form 4 holding
Director
Outlook Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 5,593
- Estimated value
- $2,399
- Report date
- 26 May 2026
- Price
- $0.4290
- Ownership
- Direct
Form 4 holding
Director
Outlook Therapeutics, Inc.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 286,734
- Estimated value
- Report date
- 01 Oct 2025
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Randy H. Thurman in Outlook Therapeutics, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.